nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—appendage—atherosclerosis	0.108	0.423	CbGeAlD
Pentosan Polysulfate—FGF4—connective tissue—atherosclerosis	0.0308	0.121	CbGeAlD
Pentosan Polysulfate—FGF1—appendage—atherosclerosis	0.0285	0.112	CbGeAlD
Pentosan Polysulfate—FGF1—artery—atherosclerosis	0.0204	0.0799	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—atherosclerosis	0.0172	0.0675	CbGeAlD
Pentosan Polysulfate—FGF1—blood vessel—atherosclerosis	0.0159	0.0623	CbGeAlD
Pentosan Polysulfate—FGF2—adipose tissue—atherosclerosis	0.0084	0.0329	CbGeAlD
Pentosan Polysulfate—FGF1—connective tissue—atherosclerosis	0.00815	0.0319	CbGeAlD
Pentosan Polysulfate—Raised liver function tests—Niacin—atherosclerosis	0.00802	0.0219	CcSEcCtD
Pentosan Polysulfate—Raised liver function tests—Pravastatin—atherosclerosis	0.00789	0.0216	CcSEcCtD
Pentosan Polysulfate—FGF1—cardiovascular system—atherosclerosis	0.00709	0.0278	CbGeAlD
Pentosan Polysulfate—FGF1—adipose tissue—atherosclerosis	0.00625	0.0245	CbGeAlD
Pentosan Polysulfate—Amblyopia—Niacin—atherosclerosis	0.00479	0.0131	CcSEcCtD
Pentosan Polysulfate—FGF1—liver—atherosclerosis	0.00438	0.0172	CbGeAlD
Pentosan Polysulfate—Vaginal inflammation—Niacin—atherosclerosis	0.0037	0.0101	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Lovastatin—atherosclerosis	0.00356	0.00974	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Niacin—atherosclerosis	0.00349	0.00956	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Ezetimibe—atherosclerosis	0.00349	0.00956	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Niacin—atherosclerosis	0.00338	0.00925	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Simvastatin—atherosclerosis	0.00333	0.00911	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Pravastatin—atherosclerosis	0.00301	0.00824	CcSEcCtD
Pentosan Polysulfate—Depression—Rosuvastatin—atherosclerosis	0.00284	0.00776	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Ezetimibe—atherosclerosis	0.00283	0.00775	CcSEcCtD
Pentosan Polysulfate—Jaundice—Rosuvastatin—atherosclerosis	0.00277	0.00758	CcSEcCtD
Pentosan Polysulfate—Gastritis—Ezetimibe—atherosclerosis	0.00272	0.00743	CcSEcCtD
Pentosan Polysulfate—Haematuria—Rosuvastatin—atherosclerosis	0.00271	0.00742	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Rosuvastatin—atherosclerosis	0.00267	0.0073	CcSEcCtD
Pentosan Polysulfate—Affect lability—Pravastatin—atherosclerosis	0.0026	0.00712	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Lovastatin—atherosclerosis	0.00259	0.00709	CcSEcCtD
Pentosan Polysulfate—Gastritis—Simvastatin—atherosclerosis	0.00259	0.00708	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Rosuvastatin—atherosclerosis	0.00256	0.007	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Rosuvastatin—atherosclerosis	0.00253	0.00693	CcSEcCtD
Pentosan Polysulfate—Mood swings—Pravastatin—atherosclerosis	0.00251	0.00685	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Niacin—atherosclerosis	0.00248	0.00678	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00247	0.00675	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Pravastatin—atherosclerosis	0.00244	0.00668	CcSEcCtD
Pentosan Polysulfate—Abdominal discomfort—Simvastatin—atherosclerosis	0.00242	0.00663	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00242	0.00662	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00231	0.00631	CcSEcCtD
Pentosan Polysulfate—Jaundice—Ezetimibe—atherosclerosis	0.0023	0.0063	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Niacin—atherosclerosis	0.00226	0.00619	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Lovastatin—atherosclerosis	0.00226	0.00619	CcSEcCtD
Pentosan Polysulfate—Depression—Simvastatin—atherosclerosis	0.00225	0.00615	CcSEcCtD
Pentosan Polysulfate—Sweating increased—Pravastatin—atherosclerosis	0.00223	0.00609	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Pravastatin—atherosclerosis	0.00223	0.00609	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Ezetimibe—atherosclerosis	0.00222	0.00607	CcSEcCtD
Pentosan Polysulfate—Jaundice—Simvastatin—atherosclerosis	0.0022	0.00601	CcSEcCtD
Pentosan Polysulfate—Flatulence—Rosuvastatin—atherosclerosis	0.00219	0.00599	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Simvastatin—atherosclerosis	0.00212	0.00579	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Ezetimibe—atherosclerosis	0.00211	0.00576	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00209	0.00571	CcSEcCtD
Pentosan Polysulfate—Weight increased—Pravastatin—atherosclerosis	0.00208	0.00569	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Pravastatin—atherosclerosis	0.00207	0.00566	CcSEcCtD
Pentosan Polysulfate—Depression—Pravastatin—atherosclerosis	0.00203	0.00556	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Niacin—atherosclerosis	0.00202	0.00552	CcSEcCtD
Pentosan Polysulfate—Jaundice—Niacin—atherosclerosis	0.00202	0.00552	CcSEcCtD
Pentosan Polysulfate—Jaundice—Pravastatin—atherosclerosis	0.00199	0.00543	CcSEcCtD
Pentosan Polysulfate—Sweating—Niacin—atherosclerosis	0.00199	0.00543	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Pravastatin—atherosclerosis	0.00191	0.00523	CcSEcCtD
Pentosan Polysulfate—Alopecia—Lovastatin—atherosclerosis	0.00191	0.00523	CcSEcCtD
Pentosan Polysulfate—Myalgia—Rosuvastatin—atherosclerosis	0.00189	0.00518	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Rosuvastatin—atherosclerosis	0.00189	0.00518	CcSEcCtD
Pentosan Polysulfate—Alopecia—Ezetimibe—atherosclerosis	0.00188	0.00513	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Niacin—atherosclerosis	0.00186	0.0051	CcSEcCtD
Pentosan Polysulfate—Flatulence—Lovastatin—atherosclerosis	0.00186	0.00508	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Pravastatin—atherosclerosis	0.00183	0.00502	CcSEcCtD
Pentosan Polysulfate—Flatulence—Ezetimibe—atherosclerosis	0.00182	0.00498	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Pravastatin—atherosclerosis	0.00182	0.00497	CcSEcCtD
Pentosan Polysulfate—Infection—Rosuvastatin—atherosclerosis	0.0018	0.00493	CcSEcCtD
Pentosan Polysulfate—Alopecia—Simvastatin—atherosclerosis	0.00179	0.00489	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00178	0.00486	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Lovastatin—atherosclerosis	0.00175	0.00478	CcSEcCtD
Pentosan Polysulfate—Flatulence—Simvastatin—atherosclerosis	0.00174	0.00475	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Niacin—atherosclerosis	0.00173	0.00474	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00171	0.00469	CcSEcCtD
Pentosan Polysulfate—Anaemia—Ezetimibe—atherosclerosis	0.00171	0.00467	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Pravastatin—atherosclerosis	0.00171	0.00467	CcSEcCtD
Pentosan Polysulfate—Malaise—Lovastatin—atherosclerosis	0.0017	0.00465	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Lovastatin—atherosclerosis	0.00169	0.00461	CcSEcCtD
Pentosan Polysulfate—Malaise—Ezetimibe—atherosclerosis	0.00167	0.00456	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00165	0.00452	CcSEcCtD
Pentosan Polysulfate—Alopecia—Niacin—atherosclerosis	0.00164	0.00449	CcSEcCtD
Pentosan Polysulfate—Insomnia—Rosuvastatin—atherosclerosis	0.00164	0.00449	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Simvastatin—atherosclerosis	0.00164	0.00447	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Rosuvastatin—atherosclerosis	0.00163	0.00446	CcSEcCtD
Pentosan Polysulfate—Anaemia—Simvastatin—atherosclerosis	0.00163	0.00445	CcSEcCtD
Pentosan Polysulfate—Alopecia—Pravastatin—atherosclerosis	0.00162	0.00442	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Lovastatin—atherosclerosis	0.0016	0.00439	CcSEcCtD
Pentosan Polysulfate—Myalgia—Lovastatin—atherosclerosis	0.0016	0.00439	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Rosuvastatin—atherosclerosis	0.0016	0.00437	CcSEcCtD
Pentosan Polysulfate—Flatulence—Niacin—atherosclerosis	0.00159	0.00436	CcSEcCtD
Pentosan Polysulfate—Malaise—Simvastatin—atherosclerosis	0.00159	0.00435	CcSEcCtD
Pentosan Polysulfate—Discomfort—Lovastatin—atherosclerosis	0.00158	0.00433	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Simvastatin—atherosclerosis	0.00158	0.00431	CcSEcCtD
Pentosan Polysulfate—Myalgia—Ezetimibe—atherosclerosis	0.00157	0.0043	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Ezetimibe—atherosclerosis	0.00157	0.0043	CcSEcCtD
Pentosan Polysulfate—Flatulence—Pravastatin—atherosclerosis	0.00157	0.00429	CcSEcCtD
Pentosan Polysulfate—Discomfort—Ezetimibe—atherosclerosis	0.00155	0.00425	CcSEcCtD
Pentosan Polysulfate—Constipation—Rosuvastatin—atherosclerosis	0.00155	0.00424	CcSEcCtD
Pentosan Polysulfate—Infection—Lovastatin—atherosclerosis	0.00153	0.00418	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Lovastatin—atherosclerosis	0.00151	0.00412	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Simvastatin—atherosclerosis	0.0015	0.0041	CcSEcCtD
Pentosan Polysulfate—Myalgia—Simvastatin—atherosclerosis	0.0015	0.0041	CcSEcCtD
Pentosan Polysulfate—Infection—Ezetimibe—atherosclerosis	0.0015	0.0041	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Rosuvastatin—atherosclerosis	0.0015	0.00409	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00148	0.00406	CcSEcCtD
Pentosan Polysulfate—Discomfort—Simvastatin—atherosclerosis	0.00148	0.00405	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Pravastatin—atherosclerosis	0.00148	0.00404	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00148	0.00404	CcSEcCtD
Pentosan Polysulfate—Anaemia—Pravastatin—atherosclerosis	0.00147	0.00403	CcSEcCtD
Pentosan Polysulfate—Anorexia—Lovastatin—atherosclerosis	0.00147	0.00401	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Niacin—atherosclerosis	0.00145	0.00396	CcSEcCtD
Pentosan Polysulfate—Urticaria—Rosuvastatin—atherosclerosis	0.00144	0.00394	CcSEcCtD
Pentosan Polysulfate—Oedema—Simvastatin—atherosclerosis	0.00144	0.00393	CcSEcCtD
Pentosan Polysulfate—Malaise—Pravastatin—atherosclerosis	0.00144	0.00393	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Rosuvastatin—atherosclerosis	0.00143	0.00392	CcSEcCtD
Pentosan Polysulfate—Infection—Simvastatin—atherosclerosis	0.00143	0.00391	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Pravastatin—atherosclerosis	0.00143	0.0039	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Simvastatin—atherosclerosis	0.00141	0.00385	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.0014	0.00383	CcSEcCtD
Pentosan Polysulfate—Insomnia—Lovastatin—atherosclerosis	0.00139	0.0038	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Lovastatin—atherosclerosis	0.00138	0.00378	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Niacin—atherosclerosis	0.00138	0.00377	CcSEcCtD
Pentosan Polysulfate—Myalgia—Niacin—atherosclerosis	0.00138	0.00377	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00137	0.00376	CcSEcCtD
Pentosan Polysulfate—Anorexia—Simvastatin—atherosclerosis	0.00137	0.00375	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Lovastatin—atherosclerosis	0.00137	0.00375	CcSEcCtD
Pentosan Polysulfate—Insomnia—Ezetimibe—atherosclerosis	0.00136	0.00373	CcSEcCtD
Pentosan Polysulfate—Myalgia—Pravastatin—atherosclerosis	0.00136	0.00371	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Pravastatin—atherosclerosis	0.00136	0.00371	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Ezetimibe—atherosclerosis	0.00135	0.0037	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Lovastatin—atherosclerosis	0.00135	0.0037	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Ezetimibe—atherosclerosis	0.00134	0.00368	CcSEcCtD
Pentosan Polysulfate—Discomfort—Pravastatin—atherosclerosis	0.00134	0.00366	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00134	0.00366	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Lovastatin—atherosclerosis	0.00134	0.00366	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Ezetimibe—atherosclerosis	0.00133	0.00363	CcSEcCtD
Pentosan Polysulfate—Oedema—Niacin—atherosclerosis	0.00132	0.00361	CcSEcCtD
Pentosan Polysulfate—Constipation—Lovastatin—atherosclerosis	0.00131	0.0036	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Ezetimibe—atherosclerosis	0.00131	0.00359	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00131	0.00358	CcSEcCtD
Pentosan Polysulfate—Insomnia—Simvastatin—atherosclerosis	0.0013	0.00356	CcSEcCtD
Pentosan Polysulfate—Oedema—Pravastatin—atherosclerosis	0.0013	0.00356	CcSEcCtD
Pentosan Polysulfate—Infection—Pravastatin—atherosclerosis	0.00129	0.00353	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Simvastatin—atherosclerosis	0.00129	0.00353	CcSEcCtD
Pentosan Polysulfate—Constipation—Ezetimibe—atherosclerosis	0.00129	0.00353	CcSEcCtD
Pentosan Polysulfate—Pruritus—Rosuvastatin—atherosclerosis	0.00128	0.00351	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Simvastatin—atherosclerosis	0.00128	0.00351	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Niacin—atherosclerosis	0.00128	0.00349	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Pravastatin—atherosclerosis	0.00127	0.00348	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Lovastatin—atherosclerosis	0.00127	0.00346	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Simvastatin—atherosclerosis	0.00127	0.00346	CcSEcCtD
Pentosan Polysulfate—Anorexia—Niacin—atherosclerosis	0.00126	0.00344	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00126	0.00344	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Pravastatin—atherosclerosis	0.00126	0.00344	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Simvastatin—atherosclerosis	0.00125	0.00342	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Ezetimibe—atherosclerosis	0.00124	0.0034	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Rosuvastatin—atherosclerosis	0.00124	0.00339	CcSEcCtD
Pentosan Polysulfate—Anorexia—Pravastatin—atherosclerosis	0.00124	0.00339	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00123	0.00337	CcSEcCtD
Pentosan Polysulfate—Constipation—Simvastatin—atherosclerosis	0.00123	0.00336	CcSEcCtD
Pentosan Polysulfate—Urticaria—Lovastatin—atherosclerosis	0.00122	0.00334	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Lovastatin—atherosclerosis	0.00122	0.00332	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.0012	0.00329	CcSEcCtD
Pentosan Polysulfate—Dizziness—Rosuvastatin—atherosclerosis	0.0012	0.00328	CcSEcCtD
Pentosan Polysulfate—Urticaria—Ezetimibe—atherosclerosis	0.0012	0.00328	CcSEcCtD
Pentosan Polysulfate—Insomnia—Niacin—atherosclerosis	0.00119	0.00327	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Ezetimibe—atherosclerosis	0.00119	0.00326	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Niacin—atherosclerosis	0.00119	0.00324	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Simvastatin—atherosclerosis	0.00119	0.00324	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00118	0.00324	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Niacin—atherosclerosis	0.00118	0.00322	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00118	0.00322	CcSEcCtD
Pentosan Polysulfate—Insomnia—Pravastatin—atherosclerosis	0.00118	0.00322	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Pravastatin—atherosclerosis	0.00117	0.00319	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Niacin—atherosclerosis	0.00116	0.00318	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Pravastatin—atherosclerosis	0.00116	0.00317	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Niacin—atherosclerosis	0.00115	0.00314	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Pravastatin—atherosclerosis	0.00114	0.00313	CcSEcCtD
Pentosan Polysulfate—Rash—Rosuvastatin—atherosclerosis	0.00114	0.00313	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Rosuvastatin—atherosclerosis	0.00114	0.00313	CcSEcCtD
Pentosan Polysulfate—Urticaria—Simvastatin—atherosclerosis	0.00114	0.00312	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Simvastatin—atherosclerosis	0.00114	0.00311	CcSEcCtD
Pentosan Polysulfate—Headache—Rosuvastatin—atherosclerosis	0.00114	0.00311	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Lovastatin—atherosclerosis	0.00113	0.0031	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Pravastatin—atherosclerosis	0.00113	0.00309	CcSEcCtD
Pentosan Polysulfate—Constipation—Pravastatin—atherosclerosis	0.00111	0.00304	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Ezetimibe—atherosclerosis	0.00111	0.00304	CcSEcCtD
Pentosan Polysulfate—Pruritus—Lovastatin—atherosclerosis	0.00109	0.00297	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Niacin—atherosclerosis	0.00108	0.00295	CcSEcCtD
Pentosan Polysulfate—Nausea—Rosuvastatin—atherosclerosis	0.00108	0.00295	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Pravastatin—atherosclerosis	0.00107	0.00293	CcSEcCtD
Pentosan Polysulfate—Pruritus—Ezetimibe—atherosclerosis	0.00107	0.00292	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00106	0.00291	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Simvastatin—atherosclerosis	0.00106	0.0029	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Lovastatin—atherosclerosis	0.00105	0.00288	CcSEcCtD
Pentosan Polysulfate—Urticaria—Niacin—atherosclerosis	0.00105	0.00287	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Niacin—atherosclerosis	0.00104	0.00285	CcSEcCtD
Pentosan Polysulfate—Urticaria—Pravastatin—atherosclerosis	0.00103	0.00282	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Ezetimibe—atherosclerosis	0.00103	0.00282	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Pravastatin—atherosclerosis	0.00103	0.00281	CcSEcCtD
Pentosan Polysulfate—Pruritus—Simvastatin—atherosclerosis	0.00102	0.00278	CcSEcCtD
Pentosan Polysulfate—Dizziness—Lovastatin—atherosclerosis	0.00102	0.00278	CcSEcCtD
Pentosan Polysulfate—Dizziness—Ezetimibe—atherosclerosis	0.000997	0.00273	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Simvastatin—atherosclerosis	0.000984	0.00269	CcSEcCtD
Pentosan Polysulfate—Vomiting—Lovastatin—atherosclerosis	0.000978	0.00267	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Niacin—atherosclerosis	0.000973	0.00266	CcSEcCtD
Pentosan Polysulfate—Rash—Lovastatin—atherosclerosis	0.000969	0.00265	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Lovastatin—atherosclerosis	0.000969	0.00265	CcSEcCtD
Pentosan Polysulfate—Headache—Lovastatin—atherosclerosis	0.000963	0.00263	CcSEcCtD
Pentosan Polysulfate—Vomiting—Ezetimibe—atherosclerosis	0.000959	0.00262	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Pravastatin—atherosclerosis	0.000958	0.00262	CcSEcCtD
Pentosan Polysulfate—Dizziness—Simvastatin—atherosclerosis	0.000951	0.0026	CcSEcCtD
Pentosan Polysulfate—Rash—Ezetimibe—atherosclerosis	0.000951	0.0026	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Ezetimibe—atherosclerosis	0.00095	0.0026	CcSEcCtD
Pentosan Polysulfate—Headache—Ezetimibe—atherosclerosis	0.000945	0.00258	CcSEcCtD
Pentosan Polysulfate—Pruritus—Niacin—atherosclerosis	0.000934	0.00255	CcSEcCtD
Pentosan Polysulfate—Pruritus—Pravastatin—atherosclerosis	0.00092	0.00252	CcSEcCtD
Pentosan Polysulfate—Vomiting—Simvastatin—atherosclerosis	0.000914	0.0025	CcSEcCtD
Pentosan Polysulfate—Nausea—Lovastatin—atherosclerosis	0.000913	0.0025	CcSEcCtD
Pentosan Polysulfate—Rash—Simvastatin—atherosclerosis	0.000907	0.00248	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Simvastatin—atherosclerosis	0.000906	0.00248	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Niacin—atherosclerosis	0.000904	0.00247	CcSEcCtD
Pentosan Polysulfate—Headache—Simvastatin—atherosclerosis	0.000901	0.00246	CcSEcCtD
Pentosan Polysulfate—Nausea—Ezetimibe—atherosclerosis	0.000896	0.00245	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Pravastatin—atherosclerosis	0.00089	0.00243	CcSEcCtD
Pentosan Polysulfate—Dizziness—Niacin—atherosclerosis	0.000873	0.00239	CcSEcCtD
Pentosan Polysulfate—Dizziness—Pravastatin—atherosclerosis	0.00086	0.00235	CcSEcCtD
Pentosan Polysulfate—Nausea—Simvastatin—atherosclerosis	0.000854	0.00234	CcSEcCtD
Pentosan Polysulfate—Vomiting—Niacin—atherosclerosis	0.00084	0.0023	CcSEcCtD
Pentosan Polysulfate—Rash—Niacin—atherosclerosis	0.000833	0.00228	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Niacin—atherosclerosis	0.000832	0.00227	CcSEcCtD
Pentosan Polysulfate—Headache—Niacin—atherosclerosis	0.000827	0.00226	CcSEcCtD
Pentosan Polysulfate—Vomiting—Pravastatin—atherosclerosis	0.000827	0.00226	CcSEcCtD
Pentosan Polysulfate—Rash—Pravastatin—atherosclerosis	0.00082	0.00224	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Pravastatin—atherosclerosis	0.000819	0.00224	CcSEcCtD
Pentosan Polysulfate—Headache—Pravastatin—atherosclerosis	0.000815	0.00223	CcSEcCtD
Pentosan Polysulfate—Nausea—Niacin—atherosclerosis	0.000784	0.00215	CcSEcCtD
Pentosan Polysulfate—Nausea—Pravastatin—atherosclerosis	0.000772	0.00211	CcSEcCtD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP3—atherosclerosis	0.000137	0.000361	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IGF2—atherosclerosis	0.000136	0.00036	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000136	0.000358	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD14—atherosclerosis	0.000136	0.000358	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CNR2—atherosclerosis	0.000135	0.000355	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—AKT1—atherosclerosis	0.000134	0.000352	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APOB—atherosclerosis	0.000132	0.000349	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VWF—atherosclerosis	0.000131	0.000347	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—VCAM1—atherosclerosis	0.000131	0.000345	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOC3—atherosclerosis	0.000131	0.000345	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EDN1—atherosclerosis	0.00013	0.000344	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LDLR—atherosclerosis	0.00013	0.000343	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL5—atherosclerosis	0.000129	0.000341	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—INS—atherosclerosis	0.000129	0.000341	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—AKT1—atherosclerosis	0.000128	0.000337	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SOCS3—atherosclerosis	0.000127	0.000335	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL18—atherosclerosis	0.000127	0.000335	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL3—atherosclerosis	0.000127	0.000335	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD40LG—atherosclerosis	0.000126	0.000333	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—LPL—atherosclerosis	0.000126	0.000333	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PRKCG—atherosclerosis	0.000123	0.000324	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AGER—atherosclerosis	0.000122	0.000322	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NCF1—atherosclerosis	0.000121	0.00032	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PRKCG—atherosclerosis	0.000121	0.000318	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APOB—atherosclerosis	0.00012	0.000317	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VWF—atherosclerosis	0.00012	0.000316	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SPP1—atherosclerosis	0.00012	0.000316	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOC3—atherosclerosis	0.000119	0.000314	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—SERPINE1—atherosclerosis	0.000119	0.000313	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LDLR—atherosclerosis	0.000118	0.000312	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CD36—atherosclerosis	0.000118	0.000311	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IFNG—atherosclerosis	0.000117	0.000309	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—IL6—atherosclerosis	0.000117	0.000308	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL18—atherosclerosis	0.000116	0.000305	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL3—atherosclerosis	0.000116	0.000305	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD40LG—atherosclerosis	0.000115	0.000304	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCR2—atherosclerosis	0.000115	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EDNRA—atherosclerosis	0.000115	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—LPL—atherosclerosis	0.000115	0.000302	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CYBA—atherosclerosis	0.000114	0.000301	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NOS3—atherosclerosis	0.000113	0.000299	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—GHRL—atherosclerosis	0.000112	0.000295	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PLAT—atherosclerosis	0.000112	0.000295	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PARP1—atherosclerosis	0.000112	0.000295	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PRKCG—atherosclerosis	0.000111	0.000294	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AGER—atherosclerosis	0.000111	0.000293	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP9—atherosclerosis	0.000111	0.000292	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PDGFB—atherosclerosis	0.000111	0.000292	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NCF1—atherosclerosis	0.000111	0.000292	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PRKCG—atherosclerosis	0.00011	0.00029	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NFKB1—atherosclerosis	0.00011	0.000289	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOB—atherosclerosis	0.000109	0.000289	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PDGFB—atherosclerosis	0.000109	0.000287	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AGT—atherosclerosis	0.000108	0.000285	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—AKT1—atherosclerosis	0.000108	0.000284	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CD36—atherosclerosis	0.000108	0.000284	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—IL6—atherosclerosis	0.000107	0.000281	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CRP—atherosclerosis	0.000106	0.00028	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NFKB1—atherosclerosis	0.000106	0.00028	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—LEP—atherosclerosis	0.000106	0.000279	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APOE—atherosclerosis	0.000106	0.000279	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—IL6—atherosclerosis	0.000105	0.000277	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CAV1—atherosclerosis	0.000105	0.000277	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—APOA1—atherosclerosis	0.000105	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCR2—atherosclerosis	0.000105	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EDNRA—atherosclerosis	0.000105	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—LPL—atherosclerosis	0.000104	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL1B—atherosclerosis	0.000104	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MAPK8—atherosclerosis	0.000104	0.000275	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CYBA—atherosclerosis	0.000104	0.000275	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PTGS2—atherosclerosis	0.000104	0.000273	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MTHFR—atherosclerosis	0.000103	0.000272	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NFKB1—atherosclerosis	0.000102	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PLAT—atherosclerosis	0.000102	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—GHRL—atherosclerosis	0.000102	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PARP1—atherosclerosis	0.000102	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—TLR4—atherosclerosis	0.000102	0.000269	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PRKCG—atherosclerosis	0.000102	0.000268	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ESR1—atherosclerosis	0.000101	0.000267	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PDGFB—atherosclerosis	0.0001	0.000265	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—F2—atherosclerosis	9.99e-05	0.000264	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—atherosclerosis	9.95e-05	0.000263	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PDGFB—atherosclerosis	9.92e-05	0.000262	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—STAT3—atherosclerosis	9.86e-05	0.00026	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—AKT1—atherosclerosis	9.84e-05	0.000259	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KNG1—atherosclerosis	9.81e-05	0.000259	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ICAM1—atherosclerosis	9.77e-05	0.000258	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AGTR1—atherosclerosis	9.76e-05	0.000257	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NFKB1—atherosclerosis	9.75e-05	0.000257	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CRP—atherosclerosis	9.69e-05	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—AKT1—atherosclerosis	9.69e-05	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NFKB1—atherosclerosis	9.69e-05	0.000255	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APOE—atherosclerosis	9.61e-05	0.000253	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MAPK8—atherosclerosis	9.58e-05	0.000253	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PIK3CG—atherosclerosis	9.56e-05	0.000252	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MAPK8—atherosclerosis	9.52e-05	0.000251	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CAV1—atherosclerosis	9.52e-05	0.000251	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PLG—atherosclerosis	9.51e-05	0.000251	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—APOA1—atherosclerosis	9.5e-05	0.00025	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MAPK3—atherosclerosis	9.42e-05	0.000248	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MTHFR—atherosclerosis	9.41e-05	0.000248	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—AKT1—atherosclerosis	9.31e-05	0.000245	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NFKB1—atherosclerosis	9.3e-05	0.000245	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—TLR4—atherosclerosis	9.29e-05	0.000245	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PDGFB—atherosclerosis	9.16e-05	0.000242	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TGFB1—atherosclerosis	9.14e-05	0.000241	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MAPK3—atherosclerosis	9.12e-05	0.000241	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—INS—atherosclerosis	9.05e-05	0.000239	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SOCS3—atherosclerosis	9e-05	0.000237	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS2—atherosclerosis	8.95e-05	0.000236	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KNG1—atherosclerosis	8.95e-05	0.000236	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ICAM1—atherosclerosis	8.91e-05	0.000235	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCL2—atherosclerosis	8.91e-05	0.000235	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AGTR1—atherosclerosis	8.9e-05	0.000235	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—STAT3—atherosclerosis	8.76e-05	0.000231	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOE—atherosclerosis	8.76e-05	0.000231	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IGF1—atherosclerosis	8.76e-05	0.000231	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP3—atherosclerosis	8.7e-05	0.000229	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CAV1—atherosclerosis	8.68e-05	0.000229	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PLG—atherosclerosis	8.67e-05	0.000229	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—APOA1—atherosclerosis	8.66e-05	0.000228	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF2—atherosclerosis	8.66e-05	0.000228	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—TNF—atherosclerosis	8.53e-05	0.000225	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOB—atherosclerosis	8.4e-05	0.000222	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MAPK3—atherosclerosis	8.37e-05	0.000221	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MAPK3—atherosclerosis	8.32e-05	0.000219	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SERPINE1—atherosclerosis	8.32e-05	0.000219	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EDN1—atherosclerosis	8.27e-05	0.000218	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SOCS3—atherosclerosis	8.21e-05	0.000217	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL5—atherosclerosis	8.21e-05	0.000216	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—INS—atherosclerosis	8.21e-05	0.000216	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS2—atherosclerosis	8.16e-05	0.000215	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—STAT3—atherosclerosis	8.09e-05	0.000213	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LPL—atherosclerosis	8.02e-05	0.000212	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NOS3—atherosclerosis	7.94e-05	0.000209	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP3—atherosclerosis	7.93e-05	0.000209	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF2—atherosclerosis	7.89e-05	0.000208	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PRKCG—atherosclerosis	7.8e-05	0.000206	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MAPK3—atherosclerosis	7.73e-05	0.000204	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOB—atherosclerosis	7.66e-05	0.000202	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SPP1—atherosclerosis	7.6e-05	0.0002	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EDN1—atherosclerosis	7.54e-05	0.000199	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SERPINE1—atherosclerosis	7.54e-05	0.000199	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—TGFB1—atherosclerosis	7.5e-05	0.000198	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL5—atherosclerosis	7.48e-05	0.000197	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—INS—atherosclerosis	7.48e-05	0.000197	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IFNG—atherosclerosis	7.44e-05	0.000196	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LPL—atherosclerosis	7.32e-05	0.000193	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NOS3—atherosclerosis	7.2e-05	0.00019	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PRKCG—atherosclerosis	7.12e-05	0.000188	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCL8—atherosclerosis	7.04e-05	0.000186	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PDGFB—atherosclerosis	7.03e-05	0.000185	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SPP1—atherosclerosis	6.93e-05	0.000183	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—IL6—atherosclerosis	6.88e-05	0.000182	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SERPINE1—atherosclerosis	6.87e-05	0.000181	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AGT—atherosclerosis	6.87e-05	0.000181	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IFNG—atherosclerosis	6.78e-05	0.000179	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOE—atherosclerosis	6.73e-05	0.000177	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—LEP—atherosclerosis	6.73e-05	0.000177	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—IL6—atherosclerosis	6.67e-05	0.000176	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CAV1—atherosclerosis	6.66e-05	0.000176	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—APOA1—atherosclerosis	6.65e-05	0.000175	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL1B—atherosclerosis	6.63e-05	0.000175	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PTGS2—atherosclerosis	6.58e-05	0.000174	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NOS3—atherosclerosis	6.56e-05	0.000173	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ESR1—atherosclerosis	6.42e-05	0.000169	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDGFB—atherosclerosis	6.41e-05	0.000169	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MMP9—atherosclerosis	6.37e-05	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—AKT1—atherosclerosis	6.35e-05	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—F2—atherosclerosis	6.34e-05	0.000167	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NFKB1—atherosclerosis	6.3e-05	0.000166	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AGT—atherosclerosis	6.26e-05	0.000165	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK8—atherosclerosis	6.19e-05	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NFKB1—atherosclerosis	6.19e-05	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—AKT1—atherosclerosis	6.15e-05	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOE—atherosclerosis	6.13e-05	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—LEP—atherosclerosis	6.13e-05	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL6—atherosclerosis	6.12e-05	0.000161	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK8—atherosclerosis	6.08e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—IL6—atherosclerosis	6.08e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CAV1—atherosclerosis	6.08e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PIK3CG—atherosclerosis	6.07e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—APOA1—atherosclerosis	6.06e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL1B—atherosclerosis	6.05e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PTGS2—atherosclerosis	6e-05	0.000158	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—AKT1—atherosclerosis	5.91e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ESR1—atherosclerosis	5.86e-05	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—F2—atherosclerosis	5.78e-05	0.000153	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—INS—atherosclerosis	5.75e-05	0.000152	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—atherosclerosis	5.72e-05	0.000151	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—STAT3—atherosclerosis	5.66e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCL2—atherosclerosis	5.65e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—IL6—atherosclerosis	5.65e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—AKT1—atherosclerosis	5.64e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NFKB1—atherosclerosis	5.64e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—AKT1—atherosclerosis	5.61e-05	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—STAT3—atherosclerosis	5.56e-05	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1—atherosclerosis	5.56e-05	0.000147	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK8—atherosclerosis	5.55e-05	0.000146	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PIK3CG—atherosclerosis	5.54e-05	0.000146	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MAPK3—atherosclerosis	5.41e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—AKT1—atherosclerosis	5.39e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MAPK3—atherosclerosis	5.31e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SERPINE1—atherosclerosis	5.28e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TGFB1—atherosclerosis	5.25e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—INS—atherosclerosis	5.24e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—AKT1—atherosclerosis	5.21e-05	0.000137	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCL2—atherosclerosis	5.16e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—STAT3—atherosclerosis	5.13e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—STAT3—atherosclerosis	5.07e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1—atherosclerosis	5.07e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NOS3—atherosclerosis	5.04e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MAPK3—atherosclerosis	4.9e-05	0.000129	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MAPK3—atherosclerosis	4.84e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SERPINE1—atherosclerosis	4.81e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—TGFB1—atherosclerosis	4.76e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—STAT3—atherosclerosis	4.68e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NOS3—atherosclerosis	4.6e-05	0.000121	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MAPK3—atherosclerosis	4.47e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCL8—atherosclerosis	4.47e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—TGFB1—atherosclerosis	4.34e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCL8—atherosclerosis	4.08e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MMP9—atherosclerosis	4.04e-05	0.000107	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NFKB1—atherosclerosis	4e-05	0.000105	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL6—atherosclerosis	3.96e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK8—atherosclerosis	3.93e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL6—atherosclerosis	3.88e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MMP9—atherosclerosis	3.69e-05	9.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—AKT1—atherosclerosis	3.65e-05	9.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NFKB1—atherosclerosis	3.65e-05	9.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—atherosclerosis	3.63e-05	9.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—STAT3—atherosclerosis	3.59e-05	9.48e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK8—atherosclerosis	3.59e-05	9.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—IL6—atherosclerosis	3.59e-05	9.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—AKT1—atherosclerosis	3.58e-05	9.45e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL6—atherosclerosis	3.54e-05	9.34e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MAPK3—atherosclerosis	3.43e-05	9.06e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TGFB1—atherosclerosis	3.33e-05	8.79e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—atherosclerosis	3.31e-05	8.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—AKT1—atherosclerosis	3.31e-05	8.72e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—STAT3—atherosclerosis	3.28e-05	8.65e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—IL6—atherosclerosis	3.27e-05	8.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—AKT1—atherosclerosis	3.27e-05	8.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MAPK3—atherosclerosis	3.13e-05	8.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TGFB1—atherosclerosis	3.04e-05	8.01e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—AKT1—atherosclerosis	3.02e-05	7.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL6—atherosclerosis	2.51e-05	6.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—AKT1—atherosclerosis	2.32e-05	6.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL6—atherosclerosis	2.29e-05	6.04e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—AKT1—atherosclerosis	2.11e-05	5.57e-05	CbGpPWpGaD
